Vanguard Group’s SCYNEXIS SCYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.11M Hold
220,290
﹤0.01% 3747
2025
Q3
$1.36M Buy
220,290
+13,200
+6% +$89.4K ﹤0.01% 3695
2025
Q2
$1.12M Hold
207,090
﹤0.01% 3712
2025
Q1
$1.58M Sell
207,090
-605
-0.3% -$5.24K ﹤0.01% 3570
2024
Q4
$2.01M Sell
207,695
-3,176
-2% -$33K ﹤0.01% 3565
2024
Q3
$2.51M Sell
210,871
-88
-0% -$1.24K ﹤0.01% 3487
2024
Q2
$3.38M Hold
210,959
﹤0.01% 3401
2024
Q1
$2.48M Buy
210,959
+16,144
+8% +$228K ﹤0.01% 3522
2023
Q4
$3.48M Buy
194,815
+8,761
+5% +$129K ﹤0.01% 3418
2023
Q3
$3.39M Buy
186,054
+2,701
+1% +$64.5K ﹤0.01% 3409
2023
Q2
$4.33M Buy
183,353
+8,905
+5% +$208K ﹤0.01% 3377
2023
Q1
$4.19M Buy
174,448
+9,123
+6% +$121K ﹤0.01% 3388
2022
Q4
$2.06M Buy
165,325
+78
+0% +$1.38K ﹤0.01% 3644
2022
Q3
$3.17M Buy
165,247
+35,730
+28% +$699K ﹤0.01% 3555
2022
Q2
$1.93M Buy
129,517
+6,960
+6% +$134K ﹤0.01% 3821
2022
Q1
$3.83M Sell
122,557
-400
-0.3% -$15.3K ﹤0.01% 3654
2021
Q4
$6M Buy
122,957
+13,706
+13% +$674K ﹤0.01% 3507
2021
Q3
$4.63M Buy
109,251
+146
+0.1% +$7.65K ﹤0.01% 3711
2021
Q2
$6.42M Buy
109,105
+832
+0.8% +$52.5K ﹤0.01% 3454
2021
Q1
$6.88M Buy
108,273
+26,946
+33% +$1.77M ﹤0.01% 3363
2020
Q4
$4.98M Buy
81,327
+45,821
+129% +$2.15M ﹤0.01% 3357
2020
Q3
$1.25M Sell
35,506
-115
-0.3% -$5.63K ﹤0.01% 3605
2020
Q2
$2.14M Buy
35,621
+674
+2% +$45.7K ﹤0.01% 3410
2020
Q1
$2.18M Buy
34,947
+301
+0.9% +$21.6K ﹤0.01% 3281
2019
Q4
$2.52M Buy
34,646
+2,395
+7% +$198K ﹤0.01% 3382
2019
Q3
$2.75M Buy
32,251
+2,579
+9% +$236K ﹤0.01% 3341
2019
Q2
$3.11M Buy
29,672
+9,586
+48% +$1.11M ﹤0.01% 3332
2019
Q1
$2.43M Buy
20,086
+3,174
+19% +$289K ﹤0.01% 3386
2018
Q4
$651K Sell
16,912
-6,236
-27% -$423K ﹤0.01% 3677
2018
Q3
$2.22M Buy
23,148
+68
+0.3% +$8.02K ﹤0.01% 3490
2018
Q2
$3.03M Buy
23,080
+2,201
+11% +$262K ﹤0.01% 3373
2018
Q1
$2.24M Buy
20,879
+9,284
+80% +$1.28M ﹤0.01% 3422
2017
Q4
$2.15M Buy
11,595
+1,183
+11% +$197K ﹤0.01% 3399
2017
Q3
$2.01M Sell
10,412
-443
-4% -$67.4K ﹤0.01% 3397
2017
Q2
$1.55M Buy
10,855
+612
+6% +$101K ﹤0.01% 3460
2017
Q1
$2.26M Buy
10,243
+2,796
+38% +$704K ﹤0.01% 3349
2016
Q4
$1.9M Buy
7,447
+142
+2% +$41.6K ﹤0.01% 3376
2016
Q3
$2.26M Buy
7,305
+5,196
+246% +$1.1M ﹤0.01% 3337
2016
Q2
$366K Hold
2,109
﹤0.01% 3844
2016
Q1
$680K Hold
2,109
﹤0.01% 3703
2015
Q4
$1.05M Buy
2,109
+8
+0.4% +$4.22K ﹤0.01% 3615
2015
Q3
$1.22M Buy
2,101
+28
+1% +$17.2K ﹤0.01% 3563
2015
Q2
$1.46M Buy
2,073
+1,268
+158% +$910K ﹤0.01% 3546
2015
Q1
$534K Buy
805
+420
+109% +$345K ﹤0.01% 3812
2014
Q4
$307K Buy
385
+6
+2% +$4.24K ﹤0.01% 3830
2014
Q3
$224K Hold
379
﹤0.01% 3872
2014
Q2
$243K Buy
+379
New +$265K ﹤0.01% 3828

Other funds holding SCYX

Vanguard Group's SCYX Position: Q4 2025 in Review

Vanguard Group held its SCYNEXIS (SCYX) position steady in Q4 2025 at 220,290 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3747.

Vanguard Group first reported a position in SCYX in Q2 2014 and has held it in 47 quarters since. The position peaked at $6.88M in Q1 2021. 38 funds tracked by Wall St. Rank hold SCYX as of Q4 2025.

  • Vanguard Group held 220,290 shares of SCYNEXIS worth $1.11M as of Q4 2025.
  • Vanguard Group left its SCYNEXIS share count unchanged in Q4 2025.
  • SCYNEXIS made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3747 holding.
  • Vanguard Group first reported a position in SCYNEXIS in Q2 2014 and has held it in 47 quarters since.
  • Vanguard Group's SCYNEXIS position peaked at $6.88M in Q1 2021.
  • 38 funds tracked by Wall St. Rank held SCYNEXIS as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.